2. Satpathy G, Behera H, Ahmed N (2017) Chlamydial eye infections: current perspectives.
Indian J Ophthalmol 65:97
3. Lijek RS, Helble JD, Olive AJ et al (2018)
Pathology after Chlamydia trachomatis infection is driven by nonprotective immune cells
that are distinct from protective populations.
Proc Natl Acad Sci 115:2216
4. Nicolle C, Cuenod A, Baizot L (1913) Etude
experimentale du trachome. Les Arch l’Institut
Pasteur Tunis 4:157–182
5. Collier LH, Blyth WA (1966) Immunogenicity
of experimental trachoma vaccines in baboons.
II. Experiments with adjuvants, and tests of
cross-protection. J Hyg (Lond) 64:529–544
6. Olsen AW, Follmann F, Erneholm K et al
(2015) Protection against chlamydia trachomatis infection and upper genital tract pathological
changes
by
vaccine-promoted
neutralizing antibodies directed to the VD4
of the major outer membrane protein. J Infect
Dis 212:978–989
7. Batteiger BE, Rank RG, Bavoil PM et al (1993)
Partial protection against genital reinfection by
immunization of guinea-pigs with isolated
outer-membrane proteins of the chlamydial
agent of guinea-pig inclusion conjunctivitis. J
Gen Microbiol 139:2965–2972
8. Badamchi-Zadeh A, McKay PF, Korber BT
et al (2016) A multi-component prime-boost
vaccination regimen with a consensus MOMP
antigen enhances chlamydia trachomatis Clearance. Front Immunol 7:162
9. Pal S, Peterson EM, de la Maza LM (2005)
Vaccination with the chlamydia trachomatis
major outer membrane protein can elicit an
immune response as protective as that resulting
from inoculation with live bacteria. Infect
Immun 73:8153–8160
10. Morrison SG, Su H, Caldwell HD et al (2000)
Immunity to murine Chlamydia trachomatis
genital tract reinfection involves B cells and
CD4+ T cells but not CD8+ T cells. Infect
Immun 68:6979–6987
11. Morrison RP, Feilzer K, Tumas DB (1995)
Gene knockout mice establish a primary protective role for major histocompatibility
complex class II-restricted responses in Chlamydia trachomatis genital tract infection. Infect
Immun 63:4661–4668
12. Plummer FA, Simonsen JN, Cameron DW et al
(1991) Cofactors in male-female sexual transmission of human immunodeficiency virus type
1. J Infect Dis 163:233–239
13. Morrison SG, Morrison RP (2001) Resolution
of secondary Chlamydia trachomatis genital
tract infection in immune mice with depletion
of both CD4+ and CD8+ T cells. Infect
Immun 69:2643–2649
14. Morrison SG, Morrison RP (2005) A predominant role for antibody in acquired immunity to
chlamydial genital tract reinfection. J Immunol
175:7536–7542
15. Scheid JF, Mouquet H, Feldhahn N et al
(2009) A method for identification of HIV
gp140 binding memory B cells in human
blood. J Immunol Methods 343:65–67
16. Hayakawa K, Ishii R, Yamasaki K et al (1987)
Isolation of high-affinity memory B cells: phycoerythrin as a probe for antigen-binding cells.
Proc Natl Acad Sci U S A 84:1379–1383
17. Doucett VP, Gerhard W, Owler K et al (2005)
Enumeration and characterization of virusspecific B cells by multicolor flow cytometry. J
Immunol Methods 303:40–52
18. Woda M, Friberg H, Currier JR et al (2016)
Dynamics of dengue virus (DENV)–specific B
cells in the response to DENV serotype 1 infections, using flow cytometry with labeled virions. J Infect Dis 214:1001–1009
19. Degauque N, Ngono AE, Akl A et al (2013)
Characterization of antigen-specific B cells
using nominal antigen-coated flow-beads.
PLoS One 8:e84273
20. Lugaajju A, Reddy SB, Ro ¨nnberg C et al
(2015) Novel flow cytometry technique for
detection of Plasmodium falciparum specific
B-cells in humans: increased levels of specific
B-cells in ongoing infection. Malar J 14:370
21. Frohlich K, Hua Z, Wang J et al (2012) Isolation of Chlamydia trachomatis and membrane
vesicles derived from host and bacteria. J
Microbiol Methods 91:222–230
28
Christopher L. Pinder et al.
Indian J Ophthalmol 65:97
3. Lijek RS, Helble JD, Olive AJ et al (2018)
Pathology after Chlamydia trachomatis infection is driven by nonprotective immune cells
that are distinct from protective populations.
Proc Natl Acad Sci 115:2216
4. Nicolle C, Cuenod A, Baizot L (1913) Etude
experimentale du trachome. Les Arch l’Institut
Pasteur Tunis 4:157–182
5. Collier LH, Blyth WA (1966) Immunogenicity
of experimental trachoma vaccines in baboons.
II. Experiments with adjuvants, and tests of
cross-protection. J Hyg (Lond) 64:529–544
6. Olsen AW, Follmann F, Erneholm K et al
(2015) Protection against chlamydia trachomatis infection and upper genital tract pathological
changes
by
vaccine-promoted
neutralizing antibodies directed to the VD4
of the major outer membrane protein. J Infect
Dis 212:978–989
7. Batteiger BE, Rank RG, Bavoil PM et al (1993)
Partial protection against genital reinfection by
immunization of guinea-pigs with isolated
outer-membrane proteins of the chlamydial
agent of guinea-pig inclusion conjunctivitis. J
Gen Microbiol 139:2965–2972
8. Badamchi-Zadeh A, McKay PF, Korber BT
et al (2016) A multi-component prime-boost
vaccination regimen with a consensus MOMP
antigen enhances chlamydia trachomatis Clearance. Front Immunol 7:162
9. Pal S, Peterson EM, de la Maza LM (2005)
Vaccination with the chlamydia trachomatis
major outer membrane protein can elicit an
immune response as protective as that resulting
from inoculation with live bacteria. Infect
Immun 73:8153–8160
10. Morrison SG, Su H, Caldwell HD et al (2000)
Immunity to murine Chlamydia trachomatis
genital tract reinfection involves B cells and
CD4+ T cells but not CD8+ T cells. Infect
Immun 68:6979–6987
11. Morrison RP, Feilzer K, Tumas DB (1995)
Gene knockout mice establish a primary protective role for major histocompatibility
complex class II-restricted responses in Chlamydia trachomatis genital tract infection. Infect
Immun 63:4661–4668
12. Plummer FA, Simonsen JN, Cameron DW et al
(1991) Cofactors in male-female sexual transmission of human immunodeficiency virus type
1. J Infect Dis 163:233–239
13. Morrison SG, Morrison RP (2001) Resolution
of secondary Chlamydia trachomatis genital
tract infection in immune mice with depletion
of both CD4+ and CD8+ T cells. Infect
Immun 69:2643–2649
14. Morrison SG, Morrison RP (2005) A predominant role for antibody in acquired immunity to
chlamydial genital tract reinfection. J Immunol
175:7536–7542
15. Scheid JF, Mouquet H, Feldhahn N et al
(2009) A method for identification of HIV
gp140 binding memory B cells in human
blood. J Immunol Methods 343:65–67
16. Hayakawa K, Ishii R, Yamasaki K et al (1987)
Isolation of high-affinity memory B cells: phycoerythrin as a probe for antigen-binding cells.
Proc Natl Acad Sci U S A 84:1379–1383
17. Doucett VP, Gerhard W, Owler K et al (2005)
Enumeration and characterization of virusspecific B cells by multicolor flow cytometry. J
Immunol Methods 303:40–52
18. Woda M, Friberg H, Currier JR et al (2016)
Dynamics of dengue virus (DENV)–specific B
cells in the response to DENV serotype 1 infections, using flow cytometry with labeled virions. J Infect Dis 214:1001–1009
19. Degauque N, Ngono AE, Akl A et al (2013)
Characterization of antigen-specific B cells
using nominal antigen-coated flow-beads.
PLoS One 8:e84273
20. Lugaajju A, Reddy SB, Ro ¨nnberg C et al
(2015) Novel flow cytometry technique for
detection of Plasmodium falciparum specific
B-cells in humans: increased levels of specific
B-cells in ongoing infection. Malar J 14:370
21. Frohlich K, Hua Z, Wang J et al (2012) Isolation of Chlamydia trachomatis and membrane
vesicles derived from host and bacteria. J
Microbiol Methods 91:222–230
28
Christopher L. Pinder et al.